Erythropoietin produced by the retina: Its role in physiology and diabetic retinopathy

Endocrine

Volumn 41, Issue 2, 2012, Pages 220-226

  Hernández, Cristina ^a   Simó, Rafael ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Diabetic retinopathy; Erythropoietin; Erythropoietin receptor; Neurodegeneration; Neuroprotection; Retina

Indexed keywords

ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; HYPOXIA INDUCIBLE FACTOR; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 2; JANUS KINASE 2; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; UNCLASSIFIED DRUG; VASCULOTROPIN;

BLOOD BRAIN BARRIER; BLOOD RETINA BARRIER; DIABETIC RETINOPATHY; ENDOTHELIAL PROGENITOR CELL; HORMONE SYNTHESIS; HUMAN; NEUROPROTECTION; NONHUMAN; PATHOGENESIS; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RETINA DEGENERATION; RETINA EDEMA; RETINA MACULA EDEMA; RETINA NEOVASCULARIZATION; REVIEW; STREPTOZOCIN DIABETES; UPREGULATION;

EID: 84862639147     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-011-9579-6     Document Type: Review

References (80)

1. P. Carnot, C. DeFlandre, Sur l'activite hemopoietique de serum au cours de la regeneration du sang. C. R. Acad. Sci. (Paris) 143, 384-386 (1906)
2. L.O. Jacobson, E. Goldwasser, W. Fried, L. Plzak, Role of the kidney in erythropoiesis. Nature 179, 633 (1957)
3. J.W. Fisher, B.J. Birdwell, Erythropoietin production by the in situ perfused kidney. Acta Haematol. 26, 224-232 (1961)
4. Z. Kuratowska, B. Lewartowski, E. Michalski, Studies on the production of erythropoietin by isolated perfused organs. Blood 18, 527-534 (1961)
5. A.J. Erslev, In vitro production of erythropoietin by kidneys perfused with a serum free solution. Blood 44, 77-85 (1974)
6. S.T. Koury, M.S. Bondurant, M.J. Koury, Localization of erythropoietin synthesizing cells in murine kidneys by in situ hybridization. Blood 71, 524-537 (1988)
7. J.W. Fisher, S. Koury, T. Ducey, S. Mendel, Erythropoietin (Epo) production by interstitial cells of hypoxic monkey kindeys. Br. J. Haematol. 95, 27-32 (1996) (Pubitemid 26340225)
8. E.D. Zanjani, J. Poster, H. Burlington, L.I. Mann, L.R. Wasserman, Liver as the primary site of erythropoietin production in the fetus. J. Lab. Clin. Med. 89, 640-644 (1977) (Pubitemid 8082916)
9. S.T. Koury, M.C. Bondurant, M.J. Koury, G.L. Semenza, Localization of cells producing erythropoietin in murine liver by in situ hybridization. Blood 77, 2497-2503 (1991)
10. T. Miyake, C.K.H. Kung, E. Goldwasser, Purification of human erythropoietin. J. Biol. Chem. 252, 5558-5564 (1977) (Pubitemid 8167007)
11. F.K. Lin, S. Suggs, C.H. Lin, J.K. Browne, R. Smailing, J.C. Egric, K.K. Chen, G.M. Fox, F. Martin, Z. Wasser, Cloning and expression of the human erythropoietin gene. Proc. Natl. Acad. Sci. USA 92, 7850-7884 (1985)
12. K. Jacobs, C. Shoemaker, R. Rudersdorf, S.D. Neill, R.J. Kaufman, A. Mufson, A. Seehra, S.S. Jones, R. Hewick, E.F. Fritsch, M. Kawakita, T. Shimiza, T. Miyoke, Isolation and characterization of genomic cDNA clones of human erythropoietin. Nature 313, 806-810 (1985) (Pubitemid 15130833)
13. J.W. Fisher, Erythropoietin: physiology and pharmacology update. Exp. Biol. Med. 228, 1-14 (2003) (Pubitemid 36077622)
14. S. Bartesaghi, M. Marinovich, E. Corsini, C.L. Galli, B. Viviani, Erythropoietin: a novel neuroprotective cytokine. Neurotoxicology 26, 923-928 (2005) (Pubitemid 41427532)
15. J.W. Fisher, Landmark advances in the development of erythropoietin. Exp. Biol. Med. 235, 1398-1411 (2010)
16. E. Morishita, S. Masuda, M. Nagao, Y. Yasuda, R. Sasaki, Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death. Neuroscience 76, 105-116 (1997) (Pubitemid 26407940)
17. L. Calvillo, R. Latini, J. Kajstura, A. Leri, P. Anversa, P. Ghezzi, M. Salio, A. Cerami, M. Brines, Recombinant human erythropoietin protects the myocardium from ischemic-reperfusion injury and promotes beneficial remodeling. Proc. Natl. Acad. Sci. 100, 4802-4806 (2003) (Pubitemid 36457809)
18. C. Moon, M. Krawczyk, D. Ahn, I. Ahmet, D. Paik, E.G. Lakatta, M. Talan, Erythropoietin reduces myocardial infarction and left ventricular function decline after coronary artery ligation in rats. Proc. Natl. Acad Sci. USA 100, 11612-11617 (2003) (Pubitemid 37205984)
19. C. Klopsch, D. Furlani, R. Gabel, W. Li, E. Pittermann, E. Uguriucan, G. Kundt, G. Zingler, U. Titze, W. Wang, L.L. Ong, K. Wagner, R.K. Li, N. Ma, G. Steinhoff, Intracardiac injection of erythropoietin induces stem cell recruitment and improves cardiac functions in a rat myocardial infarction model. J. Cell. Mol. Med. 13, 664-679 (2008)
20. A. Anagnostou, Z. Liu, M. Steiner, K. Chin, E.S. Lee, N. Kessimian, C.T. Noguchi, Erythropoietin receptor mRNA expression in human endothelial cells. Proc. Natl. Acad. Sci. USA 91, 3974-3978 (1994) (Pubitemid 24139555)
21. D. Ribatti, M. Presta, A. Vacca, R. Ria, R. Giuliani, P. Dell'Era, B. Nico, L. Roncali, F. Dammacco, Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. Blood 93, 2627-2636 (1999) (Pubitemid 29181195)
22. B. Bojana, B. Cokic, V.P. Cokie, X. Yu, B.B. Wiksler, A.N. Schechter, C.T. Noguchi, Erythropoietin and hypoxia stimulate erythropoietin receptor and nitric oxide production in endothelial cells. Blood 104, 2073-2080 (2004) (Pubitemid 39297859)
23. T.E. Peterson, Z.S. Katusic, EPO tecting the endothelium. Br. J. Pharmacol. 150, 823-825 (2007) (Pubitemid 46536626)
24. J. Chen, K.M. Connor, C.M. Aderman, L.E. Smith, Erythropoietin deficiency decreases vascular stability in mice. J. Clin. Invest. 118, 526-533 (2008) (Pubitemid 351206543)
25. E.D. Zanjani, J. Poster, H. Burlington, L.I. Mann, L.R. Wasserman, Liver as the primary site of erythropoietin formation in the liver. J. Lab. Clin. Med. 89, 640-644 (1997)
26. W. Jelkmann, Erythropoietin after a century of research: younger than ever. Eur. J. Haematol. 78, 183-205 (2007)
27. W. Jelkmann, Control of erythropoietin gene expression and its use in medicine. Methods Enzymol. 435, 179-197 (2007)
28. W. Jelkmann, Proinflammatory cytokines lowering erythropoietin production. J. Interferon. Cytokine. Res. 18, 555-559 (1992)
29. S. Gobert, V. Duprez, C. Lacombe, S. Gisselbrecht, P. Mayeux, Erythropoietin activates three forms of MAP kinase in UT7 erythroleukemia cells. Eur. J. Biochem. 234, 75-83 (1995)
30. Y. Miura, O. Muira, J.N. Ihle, N. Aoki, Activation of the mitogen activated protein kinase pathway by the erythropoietin receptor. J. Biol. Chem. 269, 29962-29969 (1994) (Pubitemid 24365166)
31. C. Pallard, G. Fabrice, C. Martine, B. Groner, S. Gisselbrecht, I. Dusanter-Fourt, Interleukin-3, erythropoietin, and prolactin activate a STAT5 line factor in lymphoid cells. J. Biol. Chem. 270, 15942-15945 (1995)
32. H. Wakao, N. Harada, T. Kitamura, A.L.F. Mui, A. Miyajima, Interleukin 2 and erythropoietin activate STAT5/MGF via distinct pathways. EMBO J. 14, 2527-2535 (1995)
33. K. Penta, S.T. Sawyer, Erythropoietin induces the tyrosine phosphorylation nuclear translocation and DNA binding of STAT1 and STAT5 in erythroid cells. J. Biol. Chem. 270, 31282-31287 (1995) (Pubitemid 26012216)
34. S.S. Watowich, A. Mikami, R.A. Busche, X. Xie, P.N. Pharr, G.D. Hongmore, P. Manduit, M. Sabbah, B. Druker, W. Vainchenker, S. Fisher, C. Lacombe, S. Gisselbreccht, Erythropoietin receptors that signal through Stat5 or Stat3 support fetal liver and adult erythropoiesis: lack of specificity of STAT signals during red blood cell development. J. Interferon. Cytokine. Res. 20, 1065-1070 (2000) (Pubitemid 32015245)
35. J.N. Ihle, Cytokine receptor signaling. Nature 377, 591-594 (1995)
36. J.E. Damen, H. Wakao, A. Miyajima, J. Krosl, R.K. Humphries, R.L. Cutler, G. Krystal, Tyrosine 343 in the erythropoietinreceptor positively regulates erythropoietin-induced cell proliferation and STAT5 activation. EMBO J. 14, 5557-5568 (1995)
37. H. Wu, U. Klingmuller, P. Besmer, H.F. Lodish, Interaction of the erythropoietin and stem-cell-factor receptors. Nature 377, 242-246 (1995)
38. M. Brines, G. Grasso, F. Fiordaliso, A. Sfacteria, P. Ghezzi, M. Fratelli, R. Latini, Q.W. Xie, J. Smart, C.J. Su-Rick, E. Pobre, D. Diaz, D. Gomez, C. Hand, T. Coleman, A. Cerami, Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor. Proc. Natl. Acad. Sci. USA 101, 14907-14912 (2004) (Pubitemid 39410773)
39. H. Ubeda, M. Brines, M. Yamin, T. Umemoto, J. Ako, S. Monomura, A. Cerami, M. Kawakami, Cardioprotection by nonerythropoietic, tissue-protective peptide mimicking the 3D structure of erythropoietin. Proc. Natl. Acad. Sci. USA 107, 14357-14362 (2010)
40. M. Brines, A. Cerami, Erythropoietin-mediated tissue protection: reducing collateral damage from the primary injury response. J. Intern. Med. 264, 405-432 (2008)
41. H.H. Marti, Erythropoietin and the hypoxic brain. J. Exp. Biol. 207, 3233-3242 (2004) (Pubitemid 39275297)
42. C. Hernández, A. Fonollosa, M. García-Ramírez et al., Erythropoietin is expressed in the human retina and it is highly elevated in the vitreous fluid of patients with diabetic macular edema. Diabetes Care 29, 2028-2033 (2006) (Pubitemid 44871182)
43. M. García-Ramírez, C. Hernández, R. Simó, Expression of erythropoietin and its receptor in the human retina: a comparative study of diabetic and nondiabetic subjects. Diabetes Care 31, 1189-1194 (2008)
44. W. Jelkmann, Effects of erythropoietin on brain function. Curr. Pharm. Biotechnol. 6, 65-79 (2005) (Pubitemid 40246754)
45. S.P. Becerra, J. Amaral, Erythropoietin: an endogenous retinal survival factor. N. Engl. J. Med. 347, 1968-1970 (2002) (Pubitemid 35429930)
46. T.S. Rex, T.Y. Wong, K. Kodali, S. Merry, Neuroprotection of photoreceptors by direct delivery of erythropoietin to the retina of the retinal degeneration slow mouse. Exp. Eye Res. 89, 735-740 (2009)
47. J. Shen, Y. Wu, J.Y. Xu, S.H. Sinclair, M. Yanoff, G. Xu, W. Li, G.T. Xu, ERK- and Akt-dependent neuroprotection by erythropoietin (EPO) against glyoxal-AGEs via modulation of Bcl-xL, Bax, and BAD. Invest. Ophthalmol. Vis. Sci. 5, 35-46 (2010)
48. O.M. Martinez-Estrada, E. Rodriguez-Millan, E. Gonzalez-De Vicente, M. Reina, S. Vilaro, M. Fabre, Erythropoietin protects the in vitro blood-brain barrier against VEGF-induced permeability. Eur. J. Neurosci. 18, 2538-2544 (2003) (Pubitemid 37452669)
49. G. Uzum, A. Sarper Diler, N. Bahcekapili, Y. Ziya Ziylan, Erythropoietin prevents the increase in blood-brain barrier permeability during pentylenetetrazol induced seizures. Life. Sci. 78, 2571-2576 (2006) (Pubitemid 44313776)
50. E.A. Friedman, F.A. L'Esperance, C.D. Brown, D.H. Berman, Treating azotemia-induced anemia with erythropoietin improves diabetic eye disease. Kidney Int. 64, S57-S63 (2003) (Pubitemid 37315509)
51. P. Villa, P. Bigini, T. Mennini, D. Agnello, T. Laragione, A. Cagnotto, B. Viviani, M. Marinovich, A. Cerami, T.R. Coleman, M. Brines, P. Ghezzi, Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis. J. Exp. Med. 198, 971-975 (2003) (Pubitemid 37152934)
52. H. Chung, H. Lee, F. Lamoke, H. Hrushesky, P.A. Wood, W.J. Jahng, Neuroprotective role of erythropoietin by anti-apoptosis in the retina. J. Neurosci. Res. 87, 2365-2374 (2009)
53. C. Heeschen, A. Aicher, R. Lehmann, S. Fichtlscherer, M. Vasa, C. Urbich, C. Mildner-Rihm, H. Martin, A.M. Zeiher, S. Dimmeler, Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. Blood 102, 1340-1346 (2003) (Pubitemid 36988041)
54. Y. Katsura, T. Okano, K. Matsuno, M. Osako, M. Kure, T. Watanabe, Y. Iwaki, M. Noritake, H. Kosano, H. Nishigori, T. Matsuoka, Erythropoietin is highly elevated in vitreous fluid of patients with proliferative diabetic retinopathy. Diabetes Care 28, 2252-2254 (2005) (Pubitemid 41242480)
55. D. Watanabe, K. Suzuma, S. Matsui, M. Kurimoto, J. Kiryu, M. Kita, I. Suzuma, H. Ohashi, T. Ojima, T. Murakami, T. Kobayashi, S. Masuda, M. Nagao, N. Yoshimura, H. Takagi, Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy. N. Engl. J. Med. 353, 782-792 (2005) (Pubitemid 41215487)
56. K. Jaquet, K. Krause, M. Tawakol-Khodai, S. Geidel, K.H. Kuck, Erythropoietin and VEGF exhibit equal angiogenic potential. Microvasc. Res. 64, 326-333 (2002)
57. J. García-Arumí, A. Fonollosa, C. Macià, C. Hernandez, V. Martinez-Castillo, A. Boixadera, M.A. Zapata, R. Simo, Vitreous levels of erythropoietin in patients with macular oedema secondary to retinal vein occlusions: a comparative study with diabetic macular oedema. Eye 23, 1066-1071 (2009)
58. A.M. Joussen, V. Poulaki, M.L. Le, K. Koizumi, C. Esser, H. Janicki, U. Schraermeyer, N. Kociok, S. Fauser, B. Kirchhof, T.S. Kern, A.P. Adamis, A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB. J. 18, 1450-1452 (2004) (Pubitemid 39561611)
59. X.M. Sun, Y.X. Zhang, Effects of glucose on growth, metabolism and EPO expresión in recombinant CHO cell cultures. Sheng. Wu. Gong. Cheng. Xue. Bao. 17, 698-702 (2001)
60. R.J. Darling, U. Kuchibhotla, W. Glaesner, R. Micanovic, D.R. Witcher, J.M. Beals, Glycosylation of erythropoietin affects receptor binding kinetics: role of electrostática interactions. Biochemistry 41, 14524-14531 (2002) (Pubitemid 35440264)
61. A.W. Gross, H.F. Lodish, Cellular trafficking and degradation of erythropoietin and novel erythropoiesis stimulating proteína (NESP). J. Biol. Chem. 281, 2024-2032 (2006) (Pubitemid 43845790)
62. A.K. Junk, A. Mammis, S.I. Savitz, M. Singh, S. Roth, S. Malhotra, P.S. Rosenbaum, A. Cerami, M. Brines, D.M. Rosenbaum, Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury. Proc. Natl. Acad. Sci. USA 99, 10659-10664 (2002)
63. C. Grimm, A. Wenzel, M. Groszer, H. Mayser, M. Seeliger, M. Samardzija, C. Bauer, M. Gassmann, C. Reme, HIF-1-induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration. Nat. Med. 8, 718-724 (2002) (Pubitemid 34778725)
64. J.C. Tsai, L. Wu, B. Worgul, M. Forbes, J. Cao, Intravitreal administration of erythropoietin and preservation of retinal ganglion cells in an experimental rat model of glaucoma. Curr. Eye Res. 30, 1025-1031 (2005) (Pubitemid 43154696)
65. C.J. Layton, J.P. Wood, G. Chidlow, N.N. Osborne, Neuronal death in primary retinal cultures is related to nitric oxide production, and is inhibited by erythropoietin in a glucose-sensitive manner. J. Neurochem. 92, 487-493 (2005) (Pubitemid 40189452)
66. J. Zhang, Y. Wu, Y. Jin, F. Ji, S.H. Sinclair, Y. Luo, G. Xu, L. Lu, W. Dai, M. Yanoff, W. Li, G.T. Xu, Intravitreal injection of erythropoietin protects both retinal vascular and neuronal cells in early diabetes. Invest. Ophthalmol. Vis. Sci. 49, 732-742 (2008)
67. Q. Wang, S. Gorbey, F. Pfister, S. Höger, A. Dorn-Beineke, K. Krügel, E. Berrone, L. Wu, T. Korff, J. Lin, S. Busch, A. Reichenbach, Y. Feng, H.P. Hammes, Long-term treatment with suberythropoietic Epo is vaso- and neuroprotective in experimental diabetic retinopathy. Cell. Physiol. Biochem. 27, 769-782 (2011)
68. L.M. Hu, Y. Luo, J. Zhang, X. Lei, J. Shen, Y. Wu, M. Qin, Y.B. Unver, Y. Zhong, G.T. Xu, W. Li, Epo reduces reactive gliosis and stimulates neurotrophin expresión in Muller cells. Front. Biosci. (Elite Ed) 3, 1541-1555 (2011)
69. M. Garcia-Ramírez, C. Hernández, M. Ruiz-Meana, M. Villarroel, L. Corraliza, D. García-Dorado, R. Simó, Erythropoietin protects retinal pigment epithelial cells against the increase of permeability induced by diabetic conditions: essential role of JAK2/PI3K signaling. Cell. Signal. 23, 1596-1602 (2011)
70. N. Sekiguchi, T. Inoguchi, K. Kobayashi, N. Sonoda, H. Nawata, Erythropoietin attenuated high glucose-induced apoptosis in cultured human aortic endothelial cells. Biochem. Biophys. Res. Commun. 334, 218-222 (2005) (Pubitemid 40978528)
71. J. Liu, P. Narasimhan, Y.S. Song, T. Nishi, F. Yu, Y.S. Lee, P.H. Chan, Epo protects SOD2-deficient mouse astrocytes from damage by oxidative stress. Glia 53, 360-365 (2006)
72. M.B. Grant, M.E. Boulton, A.V. Ljubimov, Erythropoietin: when liability becomes asset in neurovascular repair. J. Clin. Invest. 118, 467-470 (2008) (Pubitemid 351206536)
73. L.M. Hu, X. Lei, B. Ma, Y. Zhang, Y. Yan, Y.L. Wu, G.Z. Xu, W. Ye, L. Wang, G.X. Xu, G.T. Xu, L. Wei-Ye, Erythropoietin receptor positive circulating progenitor cells and endothelial progenitor cells in patients with different stages of diabetic retinopathy. Chin. Med. Sci. 26, 69-76 (2011)
74. M. Brines, N.S. Patel, P. Villa, C. Brines, T. Mennini, M. De Paola, Z. Erbayraktar, S. Erbayraktar, B. Sepodes, C. Thiemermann, P. Ghezzi, M. Yamin, C.C. Hand, Q.W. Xie, T. Coleman, A. Cerami, Nonerythropoietic, tissue-protective peptides derived from the tertiary structure of erythropoietin. Proc. Natl. Acad. Sci. USA 105, 10925-10930 (2008)
75. C.M. McVivar, R. Hamilton, L.M. Colhoun, T.A. Gardiner, M. Brines, A. Cerami, A.W. Stitt, Intervention with an erythropoietin- derived peptide protects against neuroglial and vascular degeneration during diabetic retinopathy. Diabetes 60, 2995-3005 (2011)
76. E. Eljarrat-Binstock, J. Pe'er, A.J. Domb, New techniques for drug delivery to the posterior eye segment. Pharm. Res. 27, 530-543 (2010)
77. M. Saylor, L.K. McLoon, A.R. Harrison, M.S. Lee, Experimental and clinical evidence for brimonidine as an optic nerve and retinal neuroprotective agent: an evidence-based review. Arch. Ophthalmol. 127, 402-406 (2009)
78. A. Lambiase, L. Aloe, M. Centofanti, V. Parisi, F. Mantelli, V. Colafrancesco, G.L. Manni, M.G. Bucci, S. Bonini, R. Levi- Montalcini, Experimental and clinical evidence of neuroprotection by nerve growth factor eye drops: implications for glaucoma. Proc. Natl. Acad. Sci. USA 106, 13469-13474 (2008)
79. C.J. Dong, Y. Guo, P. Agey, L. Wheeler, W.A. Hare, Alpha 2 adrenergic modulation of NMDA receptor function as a major mechanism of RGC protection in experimental glaucoma and retinal excitotoxicity. Invest. Ophthalmol. Vis. Sci. 49, 4515-4522 (2008)
80. L.P. Aiello, Targeting intraocular neovascularization and edema- one drop at a time. N. Engl. J. Med. 359, 967-969 (2008)